A pioneer in tools for the detection of HCP impurities in biopharmaceuticals and vaccines, Cygnus now offers services to identify and quantify those impurities
PhoreMost has built a pipeline of novel targets and early drug discovery programs using its next-generation “SITESEEKER®” phenotypic screening platform